Neil Klompas

2021 - Zymeworks

In 2021, Neil Klompas earned a total compensation of $1.9M as President and Chief Operating Officer former CFO at Zymeworks, a 1% increase compared to previous year.

Compensation breakdown

Option Awards$1,178,164
Salary$437,124
Stock Awards$282,913
Other$2,277
Total$1,900,478

Klompas received $1.2M in option awards, accounting for 62% of the total pay in 2021.

Klompas also received $437.1K in salary, $282.9K in stock awards and $2.3K in other compensation.

Rankings

In 2021, Neil Klompas' compensation ranked 6,229th out of 12,415 executives tracked by ExecPay. In other words, Klompas earned more than 49.8% of executives.

ClassificationRankingPercentile
All
6,229
out of 12,415
50th
Division
Manufacturing
2,639
out of 5,505
52nd
Major group
Chemicals And Allied Products
1,155
out of 2,375
51st
Industry group
Drugs
1,027
out of 2,096
51st
Industry
Pharmaceutical Preparations
745
out of 1,546
52nd
Source: SEC filing on November 25, 2022.

Klompas' colleagues

We found five more compensation records of executives who worked with Neil Klompas at Zymeworks in 2021.

2021

Ali Tehrani

Zymeworks

Chief Executive Officer

2021

Neil Josephson

Zymeworks

Chief Medical Officer

2021

Anthony Polverino

Zymeworks

Chief Scientific Officer

2021

Diana Hausman

Zymeworks

Chief Medical Officer

2021

James Priour

Zymeworks

Former Chief Commercial Officer

News

In-depth

You may also like